Blood pressure after treatment with sodium-glucose cotransporter 2 inhibitors influences renal composite outcome: Analysis using propensity score-matched models.
Kazuo KobayashiMasao ToyodaNobuo HatoriTakayuki FurukiHiroyuki SakaiTomoya UmezonoShun ItoDaisuke SuzukiHiroshi TakedaFuyuki MinagawaHisakazu DegawaHareaki YamamotoHideo MachimuraKeiichi ChinToshimasa HishikiMasahiro TakihataKouta AoyamaShinichi UmezawaKohsuke MinamisawaTogo AoyamaYoshiro HamadaYoshiro SuzukiMasahiro HayashiYutaka HatoriKazuyoshi SatoMasaaki MiyakawaKouichi TamuraAkira KanamoriPublished in: Journal of diabetes investigation (2020)
In Japanese type 2 diabetes mellitus patients with chronic kidney disease, blood pressure after SGLT2i administration influences the renal composite outcome. Blood pressure management is important, even during treatment with SGLT2i.